Compound Detail
CHEMBL59
DOPAMINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL59 |
| Name | DOPAMINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | VYFYYTLLBUKUHU-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
41
Targets
327
Activities
4
Assay Types
30
PK Parameters
20
Publications
7
Known Names
10
Indications
Molecular Properties
153.2
MW (Da)
0.60
ALogP
3
HBA
3
HBD
66.5
PSA (Ų)
0.54
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1974 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Cardiovascular Diseases Hernias, Diaphragmatic, Congenital Parkinson Disease Shock Shock, Septic Cognitive Dysfunction Heart Failure Premature Birth Depressive Disorder Diabetes Mellitus
ATC Classification
C01CA04
dopamine
Level 1: CARDIOVASCULAR SYSTEM
Level 2: CARDIAC THERAPY
Activity Summary
Ki 139 meas. best 8.92
EC50 129 meas. best 9.96
IC50 51 meas. best 8.7
Kd 8 meas. best 8.88
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| D(3) dopamine receptor CHEMBL234 | EC50 | 9.96 | 8.328 | 0.1 | 35 |
| D(2) dopamine receptor CHEMBL217 | EC50 | 9.17 | 7.3394 | 0.7 | 48 |
| D(2) dopamine receptor CHEMBL339 | EC50 | 8.96 | 8.034 | 1.1 | 5 |
| D(4) dopamine receptor CHEMBL219 | Ki | 8.92 | 7.6767 | 1.2 | 9 |
| Unchecked CHEMBL612545 | Kd | 8.88 | 8.88 | 1.3 | 1 |
| D(4) dopamine receptor CHEMBL219 | EC50 | 8.74 | 7.951 | 1.8 | 10 |
| D(2) dopamine receptor CHEMBL3998 | Ki | 8.74 | 6.822 | 1.8 | 10 |
| D(2) dopamine receptor CHEMBL217 | Ki | 8.72 | 6.7016 | 1.9 | 31 |
| D(1B) dopamine receptor CHEMBL1850 | EC50 | 8.7 | 8.7 | 2.0 | 1 |
| Dopamine receptor CHEMBL2093868 | IC50 | 8.7 | 7.55 | 2.0 | 3 |
| D(4) dopamine receptor CHEMBL3361 | EC50 | 8.62 | 8.6033 | 2.4 | 3 |
| D(1A) dopamine receptor CHEMBL2056 | EC50 | 8.59 | 7.2133 | 2.6 | 9 |
| Unchecked CHEMBL612545 | EC50 | 8.57 | 6.7275 | 2.7 | 4 |
| D(3) dopamine receptor CHEMBL234 | Ki | 8.53 | 7.3275 | 3.0 | 16 |
| Dopamine receptor CHEMBL2096970 | IC50 | 8.43 | 7.206 | 3.7 | 5 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | IC50 | 8.18 | 8.18 | 6.6 | 1 |
| D(1A) dopamine receptor CHEMBL2967 | Ki | 8.15 | 6.3829 | 7.0 | 7 |
| D(3) dopamine receptor CHEMBL3138 | Ki | 7.96 | 7.3175 | 11.0 | 4 |
| Dopamine receptor CHEMBL2096905 | IC50 | 7.82 | 7.82 | 15.0 | 1 |
| D(2) dopamine receptor CHEMBL339 | Ki | 7.82 | 6.5313 | 15.0 | 8 |
| Unchecked CHEMBL612545 | Ki | 7.82 | 6.3662 | 15.0 | 21 |
| Rattus norvegicus CHEMBL376 | IC50 | 7.54 | 7.54 | 29.0 | 1 |
| Oryctolagus cuniculus CHEMBL374 | EC50 | 7.42 | 7.2267 | 38.0 | 3 |
| Adrenergic receptor alpha-2 CHEMBL2093864 | Ki | 7.24 | 7.24 | 58.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 7.21 | 5.1275 | 61.0 | 4 |
| D(3) dopamine receptor CHEMBL3138 | IC50 | 6.96 | 6.935 | 111.0 | 2 |
| D(4) dopamine receptor CHEMBL219 | IC50 | 6.94 | 6.94 | 114.0 | 1 |
| D(1A) dopamine receptor CHEMBL2056 | Ki | 6.91 | 5.8544 | 124.0 | 9 |
| D(1A) dopamine receptor CHEMBL265 | Ki | 6.82 | 6.2675 | 150.0 | 4 |
| Sodium-dependent dopamine transporter CHEMBL338 | IC50 | 6.7 | 6.7 | 200.0 | 1 |
| D(1A) dopamine receptor CHEMBL2967 | IC50 | 6.7 | 6.7 | 200.0 | 1 |
| D(1B) dopamine receptor CHEMBL1850 | Ki | 6.64 | 6.125 | 228.0 | 2 |
| Sodium-dependent dopamine transporter CHEMBL238 | IC50 | 6.34 | 6.34 | 460.0 | 1 |
| Dopamine receptor D2 and D3 CHEMBL2111342 | IC50 | 6.32 | 6.28 | 483.0 | 2 |
| Alpha-synuclein CHEMBL6152 | IC50 | 6.28 | 5.715 | 530.0 | 2 |
| D(1A) dopamine receptor CHEMBL265 | IC50 | 6.1 | 5.6833 | 800.0 | 3 |
| Adenosine receptor A2b CHEMBL2592 | Ki | 6.01 | 6.01 | 977.2 | 1 |
| D(2) dopamine receptor CHEMBL339 | IC50 | 5.92 | 5.614 | 1200.0 | 10 |
| Rattus norvegicus CHEMBL376 | Ki | 5.84 | 5.56 | 1437.0 | 2 |
| Cavia porcellus CHEMBL369 | EC50 | 5.82 | 5.795 | 1500.0 | 2 |
| Trace amine-associated receptor 1 CHEMBL5857 | EC50 | 5.77 | 5.77 | 1710.0 | 1 |
| Sodium-dependent dopamine transporter CHEMBL238 | Ki | 5.72 | 5.455 | 1920.0 | 2 |
| D(1A) dopamine receptor CHEMBL2056 | Kd | 5.6 | 5.6 | 2500.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL2094251 | Ki | 5.6 | 5.6 | 2511.9 | 1 |
| Lysine-specific demethylase 4E CHEMBL1293226 | IC50 | 5.52 | 5.52 | 3000.0 | 1 |
| Opioid receptor CHEMBL2094129 | IC50 | 5.52 | 5.52 | 3045.0 | 1 |
| D(1A) dopamine receptor CHEMBL265 | EC50 | 5.46 | 5.38 | 3500.0 | 2 |
| Adenylate cyclase CHEMBL2095179 | EC50 | 5.46 | 5.46 | 3500.0 | 1 |
| Rattus norvegicus CHEMBL376 | EC50 | 5.46 | 5.46 | 3500.0 | 3 |
| cyclic AMP phosphoprotein CHEMBL2170 | EC50 | 5.46 | 5.46 | 3500.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| F | 20.0 | % | Homo sapiens |
| KA | 27.0 | uM | Mus musculus |
| KA | 9.2 | uM | Homo sapiens |
| KA | 13.5 | uM | Homo sapiens |
| KA | 13.5 | uM | Homo sapiens |
| KA | 9.2 | uM | Homo sapiens |
| KA | 0.89 | uM | Homo sapiens |
| KA | 14.6 | uM | Homo sapiens |
| KA | 0.13 | uM | Homo sapiens |
| KA | 7.85 | uM | Homo sapiens |
| Ka | 13.5 | uM | Homo sapiens |
| Ka | 9.2 | uM | Homo sapiens |
| Ka | 21.0 | uM | Homo sapiens |
| KA | 13.5 | uM | Homo sapiens |
| KA | 9.2 | uM | Homo sapiens |
| KA | 0.92 | uM | Homo sapiens |
| KA | 0.67 | uM | Homo sapiens |
| Ka | 9.2 | uM | Homo sapiens |
| Ka | 51.0 | uM | Methanothermobacter thermautotrophicus |
| Ka | 13.1 | uM | Saccharomyces cerevisiae |
| Ka | 13.5 | uM | Homo sapiens |
| Ka | 9.2 | uM | Homo sapiens |
| Ka | 33.2 | uM | Homo sapiens |
| Ka | 30.9 | uM | Homo sapiens |
| KA | 33.2 | uM | Homo sapiens |
| KA | 13.5 | uM | Homo sapiens |
| KA | 9.2 | uM | Homo sapiens |
| KA | 51.0 | uM | Methanothermobacter thermautotrophicus |
| KA | 54.0 | uM | Methanosarcina thermophila |
| KA | 18.4 | uM | Methanosarcina thermophila |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine